Hypoxia-driven miR-210 directly targets E2F3 to inhibit cell proliferation in various cell lines including keratinocytes, ovarian cancer cells and human embryonic kidney cells [9], [41], [42]. This evidence concerns the gene E2F3 and ovarian carcinoma.